Transcriptional Regulation: mRNA Processing, Stability, and Modifications

The transformation from DNA to a mature mRNA involves several key processing steps:
- Transcription: The initial synthesis of the pre-mRNA from the DNA template.
- 5' Capping: The addition of a protective cap to the beginning of the transcript.
- 3' Polyadenylation: The addition of a poly-A tail to the end of the transcript.
- Splicing: The removal of non-coding introns and ligation of coding exons.
- Degradation: The eventual breakdown of the mRNA molecule.
Molecular Structure of the 5' Cap (7-Methylguanosine):
- The 5' cap consists of a 7-Methylguanosine ( $m^7G$ ) residue.
- It is attached to the 5' end of the mRNA via a unique $5'\text{-to-}5'$ triphosphate linkage.
- The structure involves a methyl group ( $CH_3$ ) attached to the nitrogen at position 7 of the guanine ring ( $N+$ ).
- Additional methylations can occur on the ribose sugars of Base 1 and Base 2 at the $2'\text{-OH}$ position.

Splicing involves the precise removal of introns through two successive transesterification reactions.
Consensus Sequences and Selection Sites:
- 5' Splice Site (Donor): Defined by the sequence $GU$ . Frequencies at this site are $G (100\%)$ , $U (100\%)$ , $A/G (95\%)$ .
- 3' Splice Site (Acceptor): Defined by the sequence $AG$ . Frequencies at this site are $C (80\%)$ , $A (100\%)$ , $G (100\%)$ .
- Branch Point: Located $20\text{-}50\text{ bp}$ upstream of the 3' splice site. It contains an invariant Adenosine ( $A$ ) essential for the first step of splicing ( $100\%$ frequency).
- Pyrimidine-rich region: A sequence located between the branch point and the 3' splice site.
Step-by-Step Splicing Process:
- 1. Cleavage at the 5' splice site.
- 2. Formation of a lariat-like intermediate: The 5' end of the intron is attached to the branch point Adenosine via a $5'\text{-}2'$ phosphodiester bond (Transesterification reaction 1).
- 3. Cleavage at the 3' splice site.
- 4. Ligation of exons: The two exons are joined together via a $5'\text{-}3'$ bond (Transesterification reaction 2), and the lariat intron is released and subsequently degraded.

Alternative splicing allows a single gene to produce multiple distinct protein isoforms.
The SUMO1 Gene Example:
- Primary mRNA: $32,000\text{ nucleotides}$ .
- Mature mRNA variants include:
  - Variant 1: $1527\text{ nucleotides}$
  - Variant 2: $1078\text{ nucleotides}$
  - Variant 3: $1452\text{ nucleotides}$
- Functional Differences: The different isoforms, such as SUMOalphas, are functionally distinct as evidenced by different localization patterns observed in cellular imaging ( $20\,\mu m$ scale images show variant binding orientations).
Aberrant Splicing Responses:
- Nonsense-Mediated Decay (NMD): Triggered by a premature stop codon.
- Non-Stop Decay (NSD): Triggered when there is no stop codon present in the transcript.

mRNA degradation determines how long a message is available for translation. There are several pathways for decay:
- Deadenylation-Dependent Pathways:
  - Poly(A) shortening occurs first.
  - Followed by Decapping and subsequent $5'\text{-}3'$ exonucleolytic decay.
  - Alternatively, the Exosome performs $3'\text{-}5'$ exonucleolytic decay.
- Deadenylation-Independent Pathway: Decapping occurs directly without prior tail shortening.
- Endonucleolytic Pathway: The mRNA is cleaved internally by an endonuclease before being degraded by exonucleases.
Iron Regulation Case Study:
- High Iron conditions: The Iron Regulatory Protein (IRP) does not bind to the Iron Response Element (IRE) on the Transferrin Receptor mRNA. An IRE-specific RNase cleaves the mRNA, leading to no protein production.
- Low Iron conditions: IRP binds to the IRE, protecting the Transferrin Receptor mRNA from cleavage. The mRNA is stabilized, and the Transferrin Receptor protein is produced to bring more iron into the cell.

siRNA Pathway (Short Interfering RNA):
- Double-stranded RNA is cleaved by the enzyme Dicer into siRNAs.
- siRNAs associate with the RISC (RNA-Induced Silencing Complex).
- The siRNA is unwound, and the complex pairs with target mRNA, leading to mRNA cleavage and RISC recycling.
miRNA Pathway (MicroRNA):
- miRNAs target the RISC to the $3'$ UTR of specific mRNAs.
- This leads to either repression of translation or mRNA degradation.
RITS (RNA-Induced Transcriptional Silencing):
- miRNAs or siRNAs pair with mRNA transcripts at the target gene.
- RITS recruits a Histone Methyl-Transferase (specifically targeting Lysine 9 of Histone H3).
- This leads to heterochromatin formation and repression of transcription.

Common RNA Modifications:
- $m^6A$ (N6-methyladenosine): Affects stability, splicing, and translation efficiency.
- $m^1A$ (1-methyladenine): Affects structure and translation.
- $\Psi$ (Pseudouridine): Affects structure and translation efficiency.
- $m^7G$ (7-methylguanosine): Found at the 5' terminal cap; affects stability.
- $m^5C$ (5-methylcytidine): Affects structure and translation.
- $m^{2,2}G$ (N2,N2-dimethylguanosine): Affects stability and structure.
- $hm^5C$ (5-hydroxymethylcytidine): Affects translation efficiency.
- $ac^4C$ (N4-acetylcytidine): Affects stability and codon recognition.
Nobel Prize in Physiology or Medicine 2023:
- Awarded to Katalin Karikó and Drew Weissman.
- Recognized for discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.